[1]
Namrata Bhutani, Huda Naaz, Amol Parshuram Anbhule, Inderpreet Kaur, Tejinder Singh, and Jaswant Kaur, “Targeted Therapy for CML Patients on Imatinib: Role of Novel Variants of Human Organic Cationic Transporter 1 (hOCT1)”, DHRNI-V3, pp. 81–87, Aug. 2024.